Hepatitis C: A Disappearing Disease?
New Oral Therapies for those with Cirrhosis
UCSF Liver Transplant Conference 2014
UCSF Transplant Update
11/14/2014 - 48 minutes
Noral Terrault, MD, MPH, Director of Viral Hepatitis Research in Liver Transplantation at UCSF reviews new oral therapies available for Hepatitis C and relates the benefits and challenges for their use. Her focus is particularly on those with cirrhosis including those who are on liver transplant wait lists.
See how our technology can help your business.Explore Red Urchin >>